Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||BTRC 4017A|
BTRC 4017A is a bispecific antibody that targets both Erbb2 (Her2) and CD3, which may lead to CTL-dependent killing of Erbb2 (Her2)-expressing tumor cells (PMID: 30442682).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|BTRC 4017A||BTRC 4017A||0||1|